Cargando…

Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease

BACKGROUND: This study aimed to assess the significance of serum levels of vascular endothelial growth factor (VEGF) in non-alcoholic fatty liver disease (NAFLD). METHODS: Sixty-seven consecutive NAFLD patients and 47 healthy controls who visited our liver clinics between May 2008 and December 2010...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papageorgiou, Maria-Vasiliki, Hadziyannis, Emilia, Tiniakos, Dina, Georgiou, Anastasia, Margariti, Aikaterini, Kostas, Athanasios, Papatheodoridis, George V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320034/ https://www.ncbi.nlm.nih.gov/pubmed/28243042 http://dx.doi.org/10.20524/aog.2016.0107

Ejemplares similares

Changes in serum transforming growth factor-β1 levels in chronic hepatitis C patients under antiviral therapy
por: Kotsiri, Ioanna, et al.
Publicado: (2016)

Significance of the (13)C-caffeine breath test for patients with cirrhosis
por: Konstantinou, Dimitrios, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease may develop in individuals with normal body mass index
por: Margariti, Ekaterini, et al.
Publicado: (2012)

Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B
por: Laras, Andreas, et al.
Publicado: (2022)

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications
por: Voulgaris, Theodoros A, et al.
Publicado: (2021)

From the origin of NASH to the future of metabolic fatty liver disease
por: Geier, Andreas, et al.
Publicado: (2021)

Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay
por: Hadziyannis, Emilia, et al.
Publicado: (2013)

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
por: Govaere, Olivier, et al.
Publicado: (2023)

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
por: Hardy, Timothy, et al.
Publicado: (2017)

Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease
por: Chrysavgis, Lampros, et al.
Publicado: (2021)

Reprogramming towards endothelial cells for vascular regeneration
por: Hong, Xuechong, et al.
Publicado: (2016)

Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction
por: Pasarín, Marcos, et al.
Publicado: (2017)

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
por: Johnson, Katherine, et al.
Publicado: (2021)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
por: Boyle, Marie, et al.
Publicado: (2019)

Human vascular adhesion proteın-1 (VAP-1): Serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease
por: Kemik, Ozgur, et al.
Publicado: (2010)

RBPs Play Important Roles in Vascular Endothelial Dysfunction Under Diabetic Conditions
por: Yang, Chunbo, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

Propofol or sevoflurane anaesthesia does not affect hepatic integrity as assessed by the M30 & M65 cell death markers & liver enzymes
por: Chondrogiannis, Konstantinos, et al.
Publicado: (2014)

Evaluation of liver fibrosis: “Something old, something new…”
por: Almpanis, Zannis, et al.
Publicado: (2016)

The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
por: Giannouli, Aikaterini, et al.
Publicado: (2023)

Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease
por: McMahan, Rachel H., et al.
Publicado: (2016)

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022)

Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction
por: Ye, Xiaofeng, et al.
Publicado: (2020)

Correction: Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease.
por: McMahan, Rachel H., et al.
Publicado: (2016)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
por: Jamali, Raika, et al.
Publicado: (2016)

The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver Disease
por: Na, Ji Hoon, et al.
Publicado: (2014)

Associations between serum clusterin levels and non-alcoholic fatty liver disease
por: Wang, Yansu, et al.
Publicado: (2023)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)

Activity of Total Alcohol Dehydrogenase, Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in the Serum of Patients with Alcoholic Fatty Liver Disease
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2021)

Viral Biomarkers in Chronic HBeAg Negative HBV Infection
por: Hadziyannis, Emilia, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes
por: Montazeri, Zeinab, et al.
Publicado: (2023)

Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
por: Lee, Sang Hyub, et al.
Publicado: (2010)

Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Kumagai, Erina, et al.
Publicado: (2016)

Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women
por: Zelber-Sagi, Shira, et al.
Publicado: (2020)

Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
por: Xie, Chencheng, et al.
Publicado: (2019)

Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease
por: Amirkalali, Bahareh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ebq428o3krack8ev17ai2gadif